Research map: Downstaging as a direct patient benefit in cancer screening

Back to the article

Papers in this map

  1. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening · The National Lung Screening Trial Research Team · 2011 · 11268 citations · Cited by this paper
  2. Six-week postnatal cervical screening: Moving from acceptability toward mechanistic evidence and policy change · 2025 · Related
  3. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial · Luis G Paz-Ares · 2021 · 1397 citations · Cited by this paper
  4. Universal newborn hearing screening in Malaysian public hospitals: A national evaluation of coverage, quality indicators, and outcomes (2022–2023) · 2026 · Related
  5. Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer · Edward F. Patz · 2014 · 791 citations · Cited by this paper
  6. Colorectal cancer screening in the UK: A public health intervention of unrealised potential · 2025 · Related
  7. Prostate-Specific Antigen–Based Screening for Prostate Cancer · Joshua J. Fenton · 2018 · 566 citations · Cited by this paper
  8. Cancer screening after the age of 75: Nationwide population-based trends · 2025 · Related
  9. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force · Harry J. de Koning · 2013 · 469 citations · Cited by this paper
  10. Cost-effectiveness of fecal immunochemical testing for colorectal cancer in Mexico City: A microsimulation modeling study · 2026 · Related
  11. Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes · Grace L. Smith · 2019 · 447 citations · Cited by this paper
  12. Concurrent cancer screening participation and associated factors among Canadian women: Insights from a cross-sectional study · 2025 · Related
  13. Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer · Karen Elizabeth Hoffman · 2020 · 310 citations · Cited by this paper
  14. Prediction model to prioritize colorectal cancer screening with visual colonoscopy · 2026 · Related
  15. Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer · Thierry André · 2024 · 268 citations · Cited by this paper
  16. Is GP practice bowel, breast and cervical cancer screening coverage correlated with GP practice list inflation? · 2025 · Related
  17. Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility · Susanna B. Park · 2011 · 202 citations · Cited by this paper
  18. A retrospective cohort study investigating factors affecting recommendation for continued low-dose computed tomography lung cancer screening in the national lung cancer screening trial · 2025 · Related
  19. Impact of Cancer on Employment · Victoria Susana Blinder · 2019 · 166 citations · Cited by this paper
  20. Ripple effect of temporary self-sampling HPV test on screening uptake in the next round: A secondary analysis of the ACCESS randomized controlled trial · 2025 · Related
  21. Adjuvant Chemotherapy for Stage III Colon Cancer · Julien Taı̈eb · 2020 · 115 citations · Cited by this paper
  22. Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality · Richard Michael Martin · 2024 · 112 citations · Cited by this paper
  23. Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial · Martin Reck · 2024 · 87 citations · Cited by this paper
  24. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies · Amy Trentham‐Dietz · 2024 · 59 citations · Cited by this paper
  25. Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models · Oğuzhan Alagöz · 2018 · 46 citations · Cited by this paper
  26. Late-Stage Outcomes as Surrogates for Mortality in Cancer Screening Trials: A Systematic Review and Meta-analysis · Matejka Rebolj · 2025 · 10 citations · Cited by this paper
  27. Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial · Hari Thambiah Vigneswaran · 2025 · 6 citations · Cited by this paper
  28. Screening for prostate cancer · Jonathan Paul Bestwick · 2026 · 3 citations · Cited by this paper
  29. Adverse health outcomes for prostate cancer patients treated with radiotherapy combined with androgen-deprivation therapy: A population-based, controlled study, from Norway · Mona Nilsson · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)